University research records
Ivano-Frankivsk National Medical University
7 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →7 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Ivano-Frankivsk National Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–7 of 7 matching records. Counts update as records arrive.
EP712 - ECE_2513 - Hidden burden of iron deficiency without anemia in women with type 2 diabetes and heart failure with preserved ejection fraction
August 1, 2026 · 0 citations · Open access
Open original record →Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study
June 29, 2026 · 0 citations · Open access
Open original record →Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study
June 28, 2026 · 0 citations · Open access
Open original record →Вплив емпагліфлозину на рівень фракталкіну у хворих на цукровий діабет 2 типу
December 30, 2025 · 0 citations · Open access
Open original record →The effect of empagliflozin on fractalkine levels in patients with type 2 diabetes mellitus
December 30, 2025 · 0 citations · Open access
Open original record →Efficacy and Safety of SGLT2 Inhibitors for Preventing Heart Failure in Post-Myocardial Infarction Patients Without Established Heart Failure: A Systematic Review and Meta-Analysis
September 17, 2025 · 0 citations · Open access
Open original record →Cardioprotective effects of sodium-glucose transport protein 2 inhibitors in patients with breast cancer and concomitant type 2 diabetes mellitus undergoing chemotherapy
May 22, 2025 · 0 citations · Open access
Open original record →
